Citations for
1ADRB3, APOA1
β3-Adrenergic receptor regulates hepatic apolipoprotein A-I gene expression.
Cao X, Li Y.
J Clin Lipidol 11(5):1168-1176. doi: 10.1016/j.jacl.2017.07.007. Epub 2017 Jul 27. 2017
2APOA1, APOM
Increased mRNA levels of apolipoprotein M and apolipoprotein AI in the placental tissues with fetal macrosomia.
Yu Y, Luo GH, Zhang J, Jiang H, Wei J, Shi YP, Zhang XY, Xu N.
Arch Gynecol Obstet 291(2):299-303. doi: 10.1007/s00404-014-3441-z. Epub 2014 Sep 7. 2015
3ABCA1, APOA1
ABCA1 and nascent HDL biogenesis.
Wang S, Smith JD.
Biofactors 40(6):547-54. doi: 10.1002/biof.1187. Epub 2014 Oct 30. Review. 2014
4APOA1, APOA2, APOB, APOC1, APOC2, APOC3, APOE, CLU
Apolipoprotein localization in isolated drusen and retinal apolipoprotein gene expression.
Li CM, Clark ME, Chimento MF, Curcio CA.
Invest Ophthalmol Vis Sci 47(7):3119-28. 2006
5APOA1, APOA4, APOA5, APOC3, HLP5
Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia.
Eichenbaum-Voline S, Olivier M, Jones EL, Naoumova RP, Jones B, Gau B, Patel HN, Seed M, Betteridge DJ, Galton DJ, Rubin EM, Scott J, Shoulders CC, Pennacchio LA.
Arterioscler Thromb Vasc Biol 24(1):167-74. Epub 2003 Oct 09. 2004
6APOA1
A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease.
Hovingh GK, Brownlie A, Bisoendial RJ, Dube MP, Levels JH, Petersen W, Dullaart RP, Stroes ES, Zwinderman AH, de Groot E, Hayden MR, Kuivenhoven JA, Kastelein JJ.
J Am Coll Cardiol 44(7):1429-35. 2004
7APOA1, HDLD2
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency.
Pisciotta L, Miccoli R, Cantafora A, Calabresi L, Tarugi P, Alessandrini P, Bittolo Bon G, Franceschini G, Cortese C, Calandra S, Bertolini S.
Atherosclerosis 167(2):335-45. 2003
8APOA1, NNHA
Hereditary systemic amyloidosis with renal involvement.
Hawkins PN.
J Nephrol 16(3):443-8. Review. 2003
9APOA1, NNHA
Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.
Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, Pepys MB, Hawkins PN.
N Engl J Med 346(23):1786-91. 2002
10APOA1, LAMP2, MEAX, NNHA
The new apolipoprotein A-I variant leu(174) --> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide.
Obici L, Bellotti V, Mangione P, Stoppini M, Arbustini E, Verga L, Zorzoli I, Anesi E, Zanotti G, Campana C, Viganò M, Merlini G.
Am J Pathol 155(3):695-702. 1999
11APOA1, CCLD
A novel homozygous missense mutation in the apo A-I gene with apo A-I deficiency.
Huang W, Sasaki J, Matsunaga A, Nanimatsu H, Moriyama K, Han H, Kugi M, Koga T, Yamaguchi K, Arakawa K.
Arterioscler Thromb Vasc Biol 18(3):389-96. 1998
12APOA1, NNHA
Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene.
Booth DR, Tan SY, Booth SE, Tennent GA, Hutchinson WL, Hsuan JJ, Totty NF, Truong O, Soutar AK, Hawkins PN, Bruguera M, Caballería J, Solé M, Campistol JM, Pepys MB.
J Clin Invest 97(12):2714-21. 1996